Tag Archive

Last month the F.D.A. approved the use of esketamine as an antidepressant for individuals that have tried at least two other treatments for depression. Esketamine is the first ketamine-derived medicine, meaning that it is molecularly part of ketamine. At NMHIC, we have been aware of the use of ketamine for depression, but for a majority of the population this is …

History

In October of 2015, the idea for the NMHIC was put to paper and the proposal to create a home for bold innovation in mental health was submitted to the Anschutz Foundation, which soon after generously funded the startup Center. read more…

Give Us Your Ideas

We are committed to searching for and promoting powerful, emerging approaches that get more help to more people, earlier. We also know there is much to learn and that we can’t do it alone. We call that our Unknown Unknowns. read more...